Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ArQule Inc (NASDAQ:ARQL)

1.55
Delayed Data
As of Jan 18
 +0.02 / +1.31%
Today’s Change
1.20
Today|||52-Week Range
2.17
+23.02%
Year-to-Date

Today’s Trading

Previous close1.53
Today’s open1.54
Day’s range1.50 - 1.57
Volume62,734
Average volume (3 months)109,194
Market cap$108.8M
Dividend yield--
Data as of 3:59pm ET, 01/18/2017

Growth & Valuation

Earnings growth (last year)+40.54%
Earnings growth (this year)-51.14%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)-0.13%
P/E ratioNM
Price/Sales12.13
Price/Book3.30

Competitors

 Today’s
change
Today’s
% change
ZFGNZafgen Inc-0.02-0.50%
CXRXConcordia Internatio...-0.10-4.59%
PRQRProQR Therapeutics N...-0.10-2.22%
ECYTEndocyte Inc-0.07-2.87%
Data as of 4:00pm ET, 01/18/2017

Financials

Next reporting dateMarch 8, 2017
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$11.2M
Annual profit (last year)-$13.8M
Net profit margin-122.56%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Paolo Pucci
President &
Chief Operating Officer
Peter S. Lawrence
Corporate headquarters
Burlington, Massachusetts

Forecasts


Search for Jobs